BOSCH MARNIX L 4
4 · NORTHWEST BIOTHERAPEUTICS INC · Filed Jul 2, 2020
Insider Transaction Report
Form 4
BOSCH MARNIX L
Chief Technical Officer
Transactions
- Award
Options to purchase Common Stock, par value $0.001
2020-07-02+3,249,572→ 3,249,572 totalExercise: $0.21From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (3,249,572 underlying) - Award
Options to purchase Common Stock, par value $0.001
2020-07-02+7,549,157→ 7,549,157 totalExercise: $0.25From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (7,549,157 underlying)
Footnotes (2)
- [F1]These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.
- [F2]These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.